FDA Drug recall D-146-2013
EstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, for use as physician starter samples
- FDA Drug
- Class III
- terminated
- Published 2013-02-13
On 2013-02-13 the FDA classified a Class III recall of EstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, for use as physician starter samples by Ascend Therapeutics, citing defective Container: Pump head detaching from the canister unit upon removal of the overcap.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-146-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2012-11-19 |
| Published | 2013-02-13 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Ascend Therapeutics |
| Distribution | US |
Product
EstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, for use as physician starter samples; product is labeled in part ***Manufactured for ASCEND Therapeutics Herndon, VA 20170 by DPT Laboratories San Antonio TX 78215***
Reason
Defective Container: Pump head detaching from the canister unit upon removal of the overcap.
Identifiers
| code_info | Lot Number: EHAD Exp. 07/14 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-146-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.